RGS RGS Healthcare Solutions

Tender glossary

Loss of exclusivity (LoE)

Definition

The point at which a medicine's patents and regulatory protections expire, allowing generic or biosimilar competitors to enter the market.

In practice

In tender markets, LoE is followed by a sequence of tenders in which prices can fall steeply. Knowing which buyers will tender first, and how fast prices fell in comparable cases, is central to both originator and generic strategy.

Example

When a molecule loses exclusivity, the first tenders often set the price for the following rounds. Knowing which buyers tender first and how fast prices fell in comparable cases is central to both the originator's defence and the generic's entry plan.

Where it matters most

Back to the glossary

See how this plays out in your own tenders

RGS tracks tenders and awards across Europe and applies these rules automatically.